Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials

Antonio Yaghy(Thomas Jefferson University), Nadia K. Waheed(Tufts Medical Center), Luz D. Orozco(Bioinformatics Institute), Charles Reisman, Srinivas R. Sadda(University of California, Los Angeles), Catherine A. Cukras(Roche (Switzerland)), Anne Marie Cairns(Digital Catapult), Jonathan L. Haines(Vanderbilt University), Aaron Lee(Imperial College London), Luca Zalunardo(Institut Icare), Tiarnán D L Keenan(National Institutes of Health), Kerry Goetz(National Institutes of Health), Joseph Carroll(Medical College of Wisconsin), Christopher Mody, Amitha Domalpally(University of Wisconsin–Madison), Mary K Durbin(Topcon (Netherlands)), Cynthia Owsley(University of Alabama at Birmingham), Luís de Sisternes(Carl Zeiss (United States)), Naoto Honda(Nidek (Japan)), Sobha Sivaprasad(Moorfields Eye Hospital), Cecilia S. Lee(University of Washington), Zhihong Hu(Doheny Eye Institute), Giovanni Staurenghi(Luigi Sacco Hospital), Felix Graßmann(University of Regensburg), Stephen Poor(Novartis (United States)), Luísa S.M. Mendonça(Tufts Medical Center), Hao Chen(Zhejiang University), Daniel Sw Ting(National University of Singapore), Julie Clark, Ramiro Ribeiro(Apellis Pharmaceuticals (United States)), Santa J. Tumminia(National Institutes of Health), Pearse A. Keane(University College London)
Experimental Eye Research
May 4, 2022
Cited by 12


Related Papers